Skip to main content
Fig. 1 | Cancer Cell International

Fig. 1

From: LncRNA OIP5-AS1 promotes the malignancy of pancreatic ductal adenocarcinoma via regulating miR-429/FOXD1/ERK pathway

Fig. 1

OIP5-AS1 is upregulated in PDAC tissues and cells and predicts prognosis of PDAC patients. a OIP5-AS1 expression was analyzed in 110 PDAC tissues by RT-qPCR (**P < 0.01). b The relative expression of OIP5-AS1 in PDAC cells (PANC-1, BxPC-3, AsPC-1 and CFPAC-1) was significantly upregulated in comparison to normal pancreatic cells (HPDE6-C7). (*P< 0.05, and **P < 0.01.) c Kaplan–Meier analysis validated that higher OIP5-AS1 expression resulted in more unsatisfactory overall survival of PDAC patients (P = 0.003). *P< 0.05, and **P < 0.01 indicated data were statistically significant

Back to article page